fda retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. @adamyamaguchi The FDA has issued warning
Description
Rather than both compounds working on the same targets and potentially causing diminishing returns, they address entirely different aspects of metabolism and body composition
Get in touch with our friendly and knowledgeable team at Legacy Health to schedule your consultation and get started on the path to a healthier you

If you are currently on semaglutide and considering switching to tirzepatide through Orderly Meds or another provider, the semaglutide to tirzepatide switching chart provides the dosage equivalencies you need for a safe transition

Adding GHK-Cu to a Retatrutide protocol addresses this before it becomes a problem, during the period when the biological conditions for skin remodeling are most active, not after the weight loss has already occurred

This does not mean single-agonist medications are ineffective
